Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2009 2
2010 2
2013 1
2016 1
2017 1
2018 3
2019 2
2020 12
2021 22
2022 17
2023 21
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
Emerging Systemic Treatments for Atopic Dermatitis.
Ferrucci SM, Tavecchio S, Marzano AV, Buffon S. Ferrucci SM, et al. Dermatol Ther (Heidelb). 2023 May;13(5):1071-1081. doi: 10.1007/s13555-023-00920-4. Epub 2023 Apr 18. Dermatol Ther (Heidelb). 2023. PMID: 37072648 Free PMC article. Review.
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study.
Chiricozzi A, Ferrucci SM, Di Nardo L, Gori N, Balato A, Ortoncelli M, Maurelli M, Galluzzo M, Munera Campos M, Seremet T, Caldarola G, De Simone C, Ippoliti E, Torres T, Gkalpakiotis S, Conrad C, Carrascosa JM, Bianchi L, Argenziano G, Ribero S, Girolomoni G, Marzano AV, Peris K; MEDaCoTRA Study Group. Chiricozzi A, et al. Among authors: ferrucci sm. Expert Opin Biol Ther. 2023 Jul-Dec;23(12):1307-1315. doi: 10.1080/14712598.2023.2292627. Epub 2023 Dec 28. Expert Opin Biol Ther. 2023. PMID: 38108300
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation.
Chiricozzi A, Ortoncelli M, Schena D, Gori N, Ferrucci SM, Babino G, Napolitano M, Fargnoli MC, Stingeni L, Rossi M, Romanelli M, Balestri R, Pellegrino M, Parodi A, Bertoldi AM, Palazzo G, Antonelli F, Pitino A, Tripepi G, Fabbrocini G, Balato A, Marzano AV, Girolomoni G, Ribero S, Peris K. Chiricozzi A, et al. Among authors: ferrucci sm. Am J Clin Dermatol. 2023 Nov;24(6):953-961. doi: 10.1007/s40257-023-00798-0. Epub 2023 Jun 15. Am J Clin Dermatol. 2023. PMID: 37322324 Free PMC article.
Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study.
Calzavara-Pinton P, Čelakovská J, Lapeere H, Holzer G, Al-Ahmad M, Chu CY, Ferrucci SM, Kataoka Y, Rossi M, Fomina DS, Chung WH, Tzellos T, Fougerousse AC, Wu J, Ardeleanu M, Ozturk ZE. Calzavara-Pinton P, et al. Among authors: ferrucci sm. Adv Ther. 2023 Dec;40(12):5366-5382. doi: 10.1007/s12325-023-02644-5. Epub 2023 Oct 6. Adv Ther. 2023. PMID: 37801232 Free PMC article.
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study.
Avallone G, Mastorino L, Tavoletti G, Macagno N, Barei F, Schena D, Rossi M, Magnaterra E, Antonelli F, Babino G, Viola R, Gargiulo L, Conforti C, Rapparini L, Errichetti E, Patruno C, Ruggiero P, Roccuzzo G, Maronese CA, Girolomoni G, Gola M, Chiricozzi A, Balato A, Ambrogio F, Narcisi A, Zalaudek I, Gurioli C, Napolitano M, Marzano AV, Foti C, Costanzo A, Piraccini BM, Ferrucci SM, Ortoncelli M, Quaglino P, Ribero S. Avallone G, et al. Among authors: ferrucci sm. J Am Acad Dermatol. 2024 May;90(5):1031-1034. doi: 10.1016/j.jaad.2024.01.004. Epub 2024 Jan 9. J Am Acad Dermatol. 2024. PMID: 38199282 No abstract available.
Alopecia Areata and Toxic Metals.
Pigatto PD, Ferrucci SM, Brambilla L, Guzzi G. Pigatto PD, et al. Among authors: ferrucci sm. Skin Appendage Disord. 2020 Jun;6(3):177-179. doi: 10.1159/000507296. Epub 2020 May 16. Skin Appendage Disord. 2020. PMID: 32656240 Free PMC article.
Self-administration of omalizumab: why not? A literature review and expert opinion.
Menzella F, Ferrari E, Ferrucci SM, Lombardi E, Alfano S, Bonavita O, Morini P, Rizzi A, Matucci A. Menzella F, et al. Among authors: ferrucci sm. Expert Opin Biol Ther. 2021 Apr;21(4):499-507. doi: 10.1080/14712598.2021.1882990. Epub 2021 Feb 13. Expert Opin Biol Ther. 2021. PMID: 33504237 Review.
79 results